Funding Rounds
Orasis Pharmaceuticals

Orasis Pharma Series B round, June 2018

Orasis Pharmaceuticals

Orasis Pharmaceuticals develops a corrective eye drop to treat presbyopia as an alternative to reading glasses.

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series B

Raised Amount: $13.00M

Raised Date: 2018-06-05